Zobrazeno 1 - 5
of 5
pro vyhledávání: ''
Publikováno v:
BMC Medical Research Methodology
BMC Medical Research Methodology, BioMed Central, 2015, 15, pp.39. ⟨10.1186/s12874-015-0029-7⟩
BMC Medical Research Methodology, BioMed Central, 2015, 15, pp.39. ⟨10.1186/s12874-015-0029-7⟩
Background Cancer incidence and prevalence estimates are necessary to inform health policy, to predict public health impact and to identify etiological factors. Registers have been used to estimate the number of cancer cases. To be reliable and usefu
Autor:
Graham Watt, Una Macleod
Publikováno v:
BMC Medical Research Methodology, Vol 8, Iss 1, p 15 (2008)
BMC Medical Research Methodology
BMC Medical Research Methodology
Background Public health benefits from research often rely on the use of data from personal medical records. When neither patient consent nor anonymisation is possible, the case for accessing such records for research purposes depends on an assessmen
Publikováno v:
BMC Medical Research Methodology
BMC Medical Research Methodology, Vol 4, Iss 1, p 12 (2004)
BMC Medical Research Methodology, Vol 4, Iss 1, p 12 (2004)
Background In recent years there has been increased interest in evaluating breast cancer screening using data from before-and-after studies in multiple geographic regions. One approach, not previously mentioned, is the paired availability design. The
Autor:
Christobel Saunders, David B. Preen, Elizabeth E. Roughead, C. D'Arcy J. Holman, Max Bulsara, Kris Rogers, Anna Kemp
Publikováno v:
BMC Medical Research Methodology
Background: Statutory State-based cancer registries are considered the 'gold standard' for researchers identifying cancer cases in Australia, but research using self-report or administrative health datasets (e.g. hospital records) may not have linkag
Autor:
Mauguen, Audrey, Rachet, Bernard, Mathoulin-Pélissier, Simone, Lawrence, Gill M., Siesling, Sabine, MacGrogan, Gaëtan, Laurent, Alexandre, Rondeau, Virginie
Publikováno v:
BMC Medical Research Methodology
BMC medical research methodology, 15(1):27. BioMed Central Ltd.
BMC medical research methodology, 15(1):27. BioMed Central Ltd.
Background Cancer relapses may be useful to predict the risk of death. To take into account relapse information, the Landmark approach is popular. As an alternative, we propose the joint frailty model for a recurrent event and a terminal event to der